Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Manon Durand
Observed names:
Durand, Manon,
M. Durand
Institution:
Josep Carreras Leukaemia Research Institute
Observed institutions:
Inserm,
Université de Bourgogne,
Josep Carreras Leukaemia Research Institute,
La Ligue Contre le Cancer,
Centre de recherche Translationnelle en Médecine moléculaire
ORCID:
0000-0001-9840-2021
Observed ORCID:
0000-0001-9840-2021
OpenAlex ID:
A5066801409
Heat-Shock Proteins in Leukemia and Lymphoma: Multitargets for Innovative Therapeutic Approaches
2023
·
Vincent Cabaud-Gibouin
, Manon Durand
, et al.
·
Cancers
·
35
PDF
First-in-class inhibitor of HSP110 blocks BCR activation through SYK phosphorylation in diffuse large B-cell lymphoma
2024
·
Vincent Cabaud Gibouin
, Manon Durand
, et al.
·
Leukemia
·
10
PDF
A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma
2024
·
Manon Durand
, Vincent Cabaud Gibouin
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
10
P1217: Targeting Hsp110 in Combination With Selinexor in Primary Mediastinal B-cell Lymphoma and in Classical Hodgkin Lymphoma Inhibits Stat6 Activation and Impairs Lymphoma Cell Growth
2023
·
Manon Durand
, Vincent Cabaud Gibouin
, et al.
·
HemaSphere
·
1
The ChorioAllantoic Membrane (CAM) assay as an in vivo model for B cell lymphoma
2026
·
Barbara Chalhoub
, Laura Mondragón
, et al.
·
Methods in cell biology
Un inhibiteur de première génération de HSP110 pour potentialiser le selinexor dans le lymphome B primitif du médiastin et le lymphome de Hodgkin classique et étude du rôle des HSP dans la biogénèse des exosomes de lymphome B
2024
·
Manon Durand
·
theses.fr (ABES)
P1267: Hsp110 Favors Bcr Signaling Through Syk Phosphorylation in Diffuse Large B Cell Lymphoma
2022
·
V. Cabaud Gibouin
, C. Boudesco
, et al.
·
HemaSphere
Show more works
View as search
Works count:
10
Citation count:
56
H-index:
3
I10-index:
3
Year
Topic
Type